| 12252447 |
Multi-component inorganic capsule anchoring system based on ground-granulated blast-furnace slag |
Markus Schönlein |
2025-03-18 |
| 11306444 |
Pavement reinstatement |
— |
2022-04-19 |
| 11091428 |
Antiviral compounds |
Wolfgang Fischl, Christopher John Yarnold, Jean-Francois Pons, Mark Anthony Kerry, Patricia Amouzegh +3 more |
2021-08-17 |
| 10472341 |
Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases |
Monika Ermann, Guenther Lametschwandtner, Patricia Amouzegh, Russell Stuart Craft, Thomas Hanke +7 more |
2019-11-12 |
| D798913 |
Combined mulching tooth and depth limiter |
Collin Watts |
2017-10-03 |
| 8980927 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Eric Roy Pettipher, Graham Michael Wynne, Julia Vile, Frank Schroer |
2015-03-17 |
| 8759520 |
Compounds for treating cancer |
Stephen Peter East, Osamu Ichihara, Adrian Kotey, Smantha Jayne Bamford |
2014-06-24 |
| D699269 |
Combined mulching tooth and holder |
Collin Watts, Francis Edward Schwieger |
2014-02-11 |
| 8609696 |
Serotonin 5-HT2B receptor inhibitors |
Derek Cogan, Neil Moss, Christopher Ronald Sarko, Samantha Jayne Bamford, Pui Leng Loke +1 more |
2013-12-17 |
| 8592430 |
Quinazolin-oxime derivatives as Hsp90 inhibitors |
Stephen Martin Courtney, Owen Clifford Mather, Christopher John Yarnold, Oliver Robin Barker, Christian Montalbetti +2 more |
2013-11-26 |
| 8563536 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Eric Roy Pettipher, Graham Michael Wynne, Julia Vile, Frank Schroer |
2013-10-22 |
| 8536158 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Eric Roy Pettipher, Graham Michael Wynne, Julia Vile, Frank Schroer |
2013-09-17 |
| 8314257 |
Treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter +2 more |
2012-11-20 |
| 8206045 |
Hands-free camera holder |
Theresa M. Sweeney |
2012-06-26 |
| 8198314 |
Treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter +2 more |
2012-06-12 |
| 8163936 |
Treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter +2 more |
2012-04-24 |
| 8163931 |
Treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter +2 more |
2012-04-24 |
| 7919512 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Eric Roy Pettipher, Graham Michael Wynne, Julia Vile, Frank Schroer |
2011-04-05 |
| 7750027 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Eric Roy Pettipher, Graham Michael Wynne, Julia Vile, Frank Schroer |
2010-07-06 |
| 7582672 |
Compounds for the treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Eric Roy Pettipher +2 more |
2009-09-01 |
| 7323563 |
Hydroxamic acid derivatives as antibacterials |
Michael George Hunter, Paul Beckett, John Martin Clements, Zoe Marie Spavold |
2008-01-29 |
| 7323448 |
Antibacterial agents |
Michael George Hunter, Raymond Paul Beckett, John Martin Clements, Stephen John Davies, Lisa Marie Pratt +2 more |
2008-01-29 |
| 7148198 |
Antibacterial agents |
Michael George Hunter, Raymond Paul Beckett, John Martin Clements, Stephen John Davies, Lisa Marie Pratt +2 more |
2006-12-12 |
| 6992190 |
Hydroxamic acid derivatives as antibacterials |
Michael George Hunter, Paul Beckett, John Martin Clements, Zoe Marie Spavold |
2006-01-31 |
| 6908911 |
Antibacterial agents |
Michael George Hunter, Raymond Paul Beckett, John Martin Clements, Stephen John Davies, Lisa Marie Pratt +2 more |
2005-06-21 |